Detalhe da pesquisa
1.
PGE2 inhibits TIL expansion by disrupting IL-2 signalling and mitochondrial function.
Nature;
629(8011): 426-434, 2024 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38658764
2.
Thirty Years of Neuroscientific Investigation of Placebo and Nocebo: The Interesting, the Good, and the Bad.
Annu Rev Pharmacol Toxicol;
62: 323-340, 2022 01 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34460317
3.
Interface Gain-of-Function Mutations in TLR7 Cause Systemic and Neuro-inflammatory Disease.
J Clin Immunol;
44(2): 60, 2024 Feb 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38324161
4.
Persistently active interferon-γ pathway and expansion of T-bet+ B cells in a subset of patients with childhood-onset systemic lupus erythematosus.
Eur J Immunol;
53(7): e2250319, 2023 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37204055
5.
Long term use of interleukin-1 inhibitors reduce flare activity in patients with fibrodysplasia ossificans progressiva.
Rheumatology (Oxford);
2024 May 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38733591
6.
Long-term efficacy and safety of subcutaneous tocilizumab in clinical trials of polyarticular or systemic juvenile idiopathic arthritis.
Rheumatology (Oxford);
2024 Mar 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38552315
7.
Expansion of CD4dimCD8+ T cells characterizes macrophage activation syndrome and other secondary HLH.
Blood;
140(3): 262-273, 2022 07 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35500103
8.
Manipulating placebo analgesia and nocebo hyperalgesia by changing brain excitability.
Proc Natl Acad Sci U S A;
118(19)2021 05 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33941677
9.
Characterization of AR-CGD female patient with a novel homozygous deletion in CYBC1 gene presenting with unusual clinical phenotype.
Clin Immunol;
251: 109316, 2023 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37055004
10.
Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis.
N Engl J Med;
382(19): 1811-1822, 2020 05 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32374962
11.
Efficacy and safety of emapalumab in macrophage activation syndrome.
Ann Rheum Dis;
82(6): 857-865, 2023 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37001971
12.
The 2022 EULAR/ACR points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS).
Ann Rheum Dis;
82(10): 1271-1285, 2023 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37487610
13.
Pediatric Recurrent Pericarditis: Appropriateness of the Standard of Care and Response to IL-1 Blockade.
J Pediatr;
256: 18-26.e8, 2023 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36470465
14.
Haematological and other manifestations in the presence of antiphospholipid antibodies in a multicentric paediatric cohort.
Clin Exp Rheumatol;
41(11): 2331-2337, 2023 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37706308
15.
Hyperinflammatory syndrome in a paediatric patient with a recent diagnosis of HIV/AIDS infection: hemophagocytic lymphohistiocytosis or immune reconstitution syndrome?
BMC Infect Dis;
23(1): 477, 2023 Jul 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37464267
16.
Mutations at the C-terminus of CDC42 cause distinct hematopoietic and autoinflammatory disorders.
J Allergy Clin Immunol;
150(1): 223-228, 2022 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35157921
17.
CAR T-Cell Therapy in Autoimmune Disease.
N Engl J Med;
390(17): 1629, 2024 May 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38692298
18.
Dysregulation in B-cell responses and T follicular helper cell function in ADA2 deficiency patients.
Eur J Immunol;
51(1): 206-219, 2021 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32707604
19.
Long-term efficacy and safety of canakinumab in patients with mevalonate kinase deficiency: results from the randomised Phase 3 CLUSTER trial.
Rheumatology (Oxford);
61(5): 2088-2094, 2022 05 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34554243
20.
Canakinumab in systemic juvenile idiopathic arthritis: real-world data from a retrospective Italian cohort.
Rheumatology (Oxford);
61(4): 1621-1629, 2022 04 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34343275